| Cat. No. |
Product Name |
Information |
| PC-49678 |
YSL-109
HDAC6 inhibitor
|
YSL-109 (YSL109) is a potent, highly selective small molecule inhibitor of HDAC6 with IC50 of 0.537 nM, >4000-fold selectivity over HDAC1 and HDAC8. |
| PC-49539 |
GH8HA01
HDAC8 inhibitor
|
GH8HA01 is a highly potent, selective HDAC8 inhibitor with Ki of 0.67 nM, highly selective against HDAC8 compared to other HDACs. |
| PC-49452 |
NN-429
HDAC6 inhibitor
|
NN-429 (NN429) is a potent, selective second-generation inhibitor of HDAC6 with IC50 of 3.2 nM, >312-fold selectivityt over all HDAC isoforms. |
| PC-49363 |
DKFZ-748
HDAC10 inhibitor
|
DKFZ-748 (DKFZ748) is a potent, specific HDAC10 inhibitor with cellular IC50 of 22 nM, >500-fold selectivity over other HDAC isozymes. |
| PC-38799 |
NQN-1
HDAC6 inhibitor
|
NQN-1 is a highly selective, small molecule HDAC6 inhibitor with IC50 of 5.54 uM and Ki of 1.30 uM. |
| PC-38796 |
A452
HDAC6 inhibitor
|
A452 is a potent and selective HDAC6 inhibitor, effectively inhibits the cell growth and viability of various cancer cell types, irrespective of p53 status. |
| PC-73237 |
UBD253
HDAC6-ISG15 inhibitor
|
UBD253 (SGC-UBD253) is a potent, selective ubiquitin chemical probe for ubiquitin binding domain of HDAC6 with Kd of 84 nM (SPR), inhibits the HDAC6-ISG15 interaction (EC50=1.9 uM, nanoBRET). |
| PC-73193 |
Rocilinostat
HDAC6 inhibitor
|
Ricolinostat (ACY-1215) is a potent and selective HDAC6 inhibitor with IC50 of 5 nM. |
| PC-72875 |
MJM-1
HDAC inhibitor
|
MJM-1 is a small-molecule brain-penetrant HDAC inhibitor that increases the overall level of histone 3 (H3) acetylation in prostate cancer cell line. |
| PC-72740 |
NN-390
HDAC6 inhibitor.
|
NN-390 (NN390) is a potent, selective HDAC6 inhibitor with IC50 of 9.8 nM, >200-550-fold selectivity over other HDAC isoforms. |
| PC-72344 |
SW-101
HDAC6 inhibitor
|
SW-101 (SW101) is a potent, selective HDAC6 inhibitor with IC50 of 0.7 nM, >200-fold selectivity over HDAC1/2/3. |
| PC-72343 |
HDAC3 inhibitor PT3
HDAC3 inhibitor
|
HDAC3 inhibitor PT3 is a novel potent, selective, BBB-permeable HDAC3 inhibitor. |
